Celldex Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2017 | $79.3M | $315.6M | $40.3M |
| FY2018 | $31.7M | $155.8M | $24.3M |
| FY2019 | $28.9M | $122.9M | $11.2M |
| FY2020 | $26.5M | $235.8M | $43.8M |
| FY2021 | $25.2M | $444.7M | $39.1M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2017 | $79.3M | $315.6M | $40.3M |
| FY2018 | $31.7M | $155.8M | $24.3M |
| FY2019 | $28.9M | $122.9M | $11.2M |
| FY2020 | $26.5M | $235.8M | $43.8M |
| FY2021 | $25.2M | $444.7M | $39.1M |